Article
Immune-Related Genes for the Prediction of Response to Imatinib therapy in Chronic Myeloid Leukemia
2023-07-05
Abstract excerpt
<h4>Background: </h4> Chronic myeloid leukemia (CML) is a malignant hyperplastic tumor that originates from pluripotent hematopoietic stem cells in the bone marrow. The introduction of tyrosine kinase inhibitors (TKIs) has significantly enhanced the survival rate of CML patients. This study aimed to identify immune-related genes (IRGs) associated with the response to imatinib therapy in CML. Methods. We obtained g...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- fa0f935c-e0de-5e33-a7d1-532151e223e8
- DOI
- 10.21203/rs.3.rs-3124281/v1
